This webinar highlights how a leading contract lab successfully validated and implemented ATP-bioluminescence for microbial detection in compliance with European Pharmacopeia 5.1.6 and USP <1223>, and will subsequently comply with USP <73> upon its release. A case study will be presented, which explores their approach and how the method is adaptable to your sterility testing.

Click here for more information and to register.